Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Jun. 28, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):

	Consumer Healthcare			Nutritionals		Rx Pharma- ceuticals		API		Specialty Sciences		Total
Balance as of June 30, 2012	$	138.9		$	331.7	$	220.8	$	86.3	$	—	$	777.8
Business acquisitions	144.7			—		163.9		—		—		308.6
Currency translation adjustment	(3.7		)	—		0.7		5.9		—		2.9
Balance as of June 29, 2013	279.9			331.7		385.4		92.2		—		1,089.2
Business acquisitions	1,118.8			178.4		851.0		—		201.8		2,350.0
Currency translation adjustment	7.6			—		21.9		5.4				34.9
Balance as of June 28, 2014	$	1,406.3		$	510.1	$	1,258.3	$	97.6	$	201.8	$	3,474.1

Schedule of Finite and Indefinite-Lived Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):

	June 28, 2014				June 29, 2013
	Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Distribution and license agreements	$	6,027.3	$	192.1	$	192.7	$	28.9
Developed product technology/formulation and product rights	931.7		302.5		896.8		204.6
Customer relationships	372.0		97.5		358.2		72.4
Trade names and trademarks	47.8		5.6		12.7		4.2
Non-compete agreements	15.3		9.4		13.3		6.0
Total	$	7,394.1	$	607.1	$	1,473.7	$	316.1
Non-amortizable intangibles:
Trade names and trademarks	$	59.5	$	—	$	57.0	$	—
In-process research and development	10.2		—		27.8		—
Total	69.7		—		84.8		—
Total other intangible assets	$	7,463.8	$	607.1	$	1,558.5	$	316.1

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

The estimated amortization expense for each of the following years is as follows (in millions):

Fiscal Year	Amount
2015	$	427.0
2016	438.0
2017	434.0
2018	427.0
2019	416.0
Thereafter	4,645.0